中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2008年
1期
26-28
,共3页
潘小平%尹平%杨富英%陈小辉%李泽%李蒙燕%郑浩%欧阳樱君%杨长萍%邹志军%叶燕芯%邓慧琨
潘小平%尹平%楊富英%陳小輝%李澤%李矇燕%鄭浩%歐暘櫻君%楊長萍%鄒誌軍%葉燕芯%鄧慧琨
반소평%윤평%양부영%진소휘%리택%리몽연%정호%구양앵군%양장평%추지군%협연심%산혜곤
脑卒中%心理干预%预后%免疫功能
腦卒中%心理榦預%預後%免疫功能
뇌졸중%심리간예%예후%면역공능
Stroke%Psychological intervention%Prognosis%Immune function
目的 研究心理干预对脑卒中患者预后及免疫功能影响的临床意义.方法 将102名脑卒中患者随机分为对照组53例,干预组49例.两组患者均采用脑卒中后常规治疗和护理.干预组同时实施心理干预.在治疗前、治疗后1个月、治疗后6个月分别对两组患者进行生存质量量表(WHOQOL-BREF)、综合医院焦虑抑郁量表(HADS)、改良爱丁堡斯堪的那维亚卒中量表(MESSS)评定,同时对免疫球蛋白IgA、IgG、IgE、IgM、补体C3、C4及皮质醇进行测定.结果 治疗前,除焦虑和抑郁评分干预组明显高于对照组(P<0.05)外,其余指标两组无明显差异(P>0.05).1个月后,IgA水平干预组高于对照组(P<0.05),余无明显差异(P>0.05).6个月后,IgA、IgE、C4、生存质量量表评分干预组明显高于对照组(P<0.05),卒中量表评分干预组明显低于对照组(P<0.05),余指标两组差异无显著性(P>0.05).结论 心理干预对提高脑卒中患者的生存质量,改善预后有着积极的临床意义.
目的 研究心理榦預對腦卒中患者預後及免疫功能影響的臨床意義.方法 將102名腦卒中患者隨機分為對照組53例,榦預組49例.兩組患者均採用腦卒中後常規治療和護理.榦預組同時實施心理榦預.在治療前、治療後1箇月、治療後6箇月分彆對兩組患者進行生存質量量錶(WHOQOL-BREF)、綜閤醫院焦慮抑鬱量錶(HADS)、改良愛丁堡斯堪的那維亞卒中量錶(MESSS)評定,同時對免疫毬蛋白IgA、IgG、IgE、IgM、補體C3、C4及皮質醇進行測定.結果 治療前,除焦慮和抑鬱評分榦預組明顯高于對照組(P<0.05)外,其餘指標兩組無明顯差異(P>0.05).1箇月後,IgA水平榦預組高于對照組(P<0.05),餘無明顯差異(P>0.05).6箇月後,IgA、IgE、C4、生存質量量錶評分榦預組明顯高于對照組(P<0.05),卒中量錶評分榦預組明顯低于對照組(P<0.05),餘指標兩組差異無顯著性(P>0.05).結論 心理榦預對提高腦卒中患者的生存質量,改善預後有著積極的臨床意義.
목적 연구심리간예대뇌졸중환자예후급면역공능영향적림상의의.방법 장102명뇌졸중환자수궤분위대조조53례,간예조49례.량조환자균채용뇌졸중후상규치료화호리.간예조동시실시심리간예.재치료전、치료후1개월、치료후6개월분별대량조환자진행생존질량량표(WHOQOL-BREF)、종합의원초필억욱량표(HADS)、개량애정보사감적나유아졸중량표(MESSS)평정,동시대면역구단백IgA、IgG、IgE、IgM、보체C3、C4급피질순진행측정.결과 치료전,제초필화억욱평분간예조명현고우대조조(P<0.05)외,기여지표량조무명현차이(P>0.05).1개월후,IgA수평간예조고우대조조(P<0.05),여무명현차이(P>0.05).6개월후,IgA、IgE、C4、생존질량량표평분간예조명현고우대조조(P<0.05),졸중량표평분간예조명현저우대조조(P<0.05),여지표량조차이무현저성(P>0.05).결론 심리간예대제고뇌졸중환자적생존질량,개선예후유착적겁적림상의의.
Objective The clinical effects of psychological intervention on prognosis and immune func-tion of patients with stroke were investigated. Methods 102 patients with stroke were arranged randomly into control group 53 and interventional group 49. Patients which both were treated with general post-stroke treatment and nurse. And meanwhile only the interventional group was treated with psychological intervention. Both groups were evaluated respectively with World Health Organization Quality Of Life-bref (WHOQOL-BREF),Hospital Anxiety Depression Scal (HADS), Modification Edinburgh Scandinavian Stroke Scal (MESSS) in prior-treat-ment, post-treatment 1 month and post-treatment 6 month. Three phasrs IgA,IgG, IgM, IgE, C3, C4, and Cor-tieosteroid were also measured. Results Before treatment,the values of anxiety and depression in the interven-tional group were Significantly higher than those in the control group (P<0.05). There were no other differ-ences (P>0.05). Post-treatment 1 month, the values of IgA, in the interventional group were signticantly high-er than those in the control group (P<0.05). There were no differences (P>0.05). Post-treatment 6 month,The values of IgA, IgE, C4 and WHOQOL-BREF, in the interventional group were significanthy higher than those in the control group (P<0.05). The values of MESSS in the interventional group is significantly lower the those of MESSS in the control group (P<0.05). There were no other differences (P>0.05). Conclusion It is clinically important for psychological intervention to improve the quality of life and prognosis of patients with stroke.
